Listed

Phio Pharmaceuticals Corp.

PHIONasdaqCIK 1533040HealthcareFiscal year ends Dec 31

Reports and events: 316 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Phio Pharmaceuticals Corp., Reports and events
FiledFormWhat it isAccession number
2020-01-1417:00 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-20-000141
2020-01-1017:21 ET8-K5.07 Shareholder vote results0001683168-20-000082
2019-12-1807:30 ET8-K8.01 Other events0001683168-19-004008
2019-12-0617:15 ET8-K/A3.01 Delisting notice; 9.01 Financial statements and exhibits0001683168-19-003908
2019-11-2217:22 ETDEF 14AProxy statementPeriod 2019-12-120001683168-19-003804
2019-11-2021:29 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001683168-19-003762
2019-11-1217:20 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001683168-19-003555
2019-11-1207:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-19-003527
2019-11-1207:31 ET10-QQuarterly reportPeriod 2019-09-300001683168-19-003526
2019-11-0817:12 ET8-K/A5.07 Shareholder vote results0001683168-19-003511
2019-10-2517:25 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results0001683168-19-003370
2019-10-0118:40 ETS-1Registration statement0001683168-19-003116
2019-09-2517:07 ETS-1/ARegistration statement, amended0001683168-19-003041
2019-08-3017:27 ETS-1Registration statement0001683168-19-002795
2019-08-3017:27 ETDEF 14AProxy statementPeriod 2019-08-220001683168-19-002796
2019-08-1217:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-19-002550
2019-08-1217:01 ET10-QQuarterly reportPeriod 2019-06-300001683168-19-002547
2019-08-0917:20 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001683168-19-002524
2019-05-1417:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-19-001520
2019-05-1417:16 ET10-QQuarterly reportPeriod 2019-03-310001683168-19-001519
2019-03-2717:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-19-000798
2019-03-2717:11 ET10-KAnnual reportPeriod 2018-12-310001683168-19-000795
2019-02-1517:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001683168-19-000423
2019-01-2817:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001683168-19-000206
2018-12-2107:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001683168-18-003773
2018-11-1917:00 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-18-003505
2018-11-1407:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-18-003391
2018-11-1407:06 ET10-QQuarterly reportPeriod 2018-09-300001683168-18-003390
2018-11-1317:20 ET8-K3.01 Delisting notice0001683168-18-003381
2018-10-0517:00 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-18-002979
2018-09-2806:04 ETS-1/ARegistration statement, amended0001683168-18-002882
2018-09-2608:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-18-002841
2018-09-1417:28 ETS-1/ARegistration statement, amended0001683168-18-002758
2018-09-0407:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001683168-18-002589
2018-08-3117:21 ETS-1Registration statement0001683168-18-002585
2018-08-2109:25 ET8-K8.01 Other events0001683168-18-002438
2018-08-1409:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-18-002283
2018-08-1409:11 ET10-QQuarterly reportPeriod 2018-06-300001683168-18-002282
2018-06-0817:02 ET8-K5.07 Shareholder vote results0001683168-18-001640
2018-06-0117:16 ET8-K3.01 Delisting notice0001193125-18-181966
2018-05-1007:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-158336
2018-05-1007:07 ET10-QQuarterly reportPeriod 2018-03-310001193125-18-158327
2018-05-0917:22 ETS-1Registration statement0001193125-18-157718
2018-04-2616:46 ETDEF 14AProxy statementPeriod 2018-06-050001193125-18-135022
2018-04-1116:32 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-18-114322
2018-03-2917:16 ET8-K3.01 Delisting notice0001193125-18-102213
2018-03-2710:11 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-18-096928
2018-03-2616:52 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-096062
2018-03-2616:49 ET10-KAnnual reportPeriod 2017-12-310001193125-18-096053
2018-03-2616:44 ET10-Q/AQuarterly report, amendedPeriod 2017-09-300001193125-18-096031

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 20:44 ET. Listed shows no prices and gives no investment advice.